CRMY Initiates “Support Our Scientist” Drive to Advance Cancer Research
“Save Our Ship,” or SOS, takes on a fresh significance at Cancer Research Malaysia (CRMY), now symbolizing “Support Our Scientists.”
Established in 2000, Cancer Research Malaysia (CRMY) stands as the nation’s pioneering and sole independent, non-profit cancer research organization. Solely reliant on donations and research grants, it diligently pursues cancer research to enhance survival rates, with a particular focus on the Asian populace.
CRMY has initiated its “Support Our Scientist” campaign, offering individuals the chance to contribute to groundbreaking cancer research. This initiative spotlights two vital research units: Digital Health and Cancer Immunology & Immunotherapy. Representing the Digital Health department are Dr. Senthilmani Rajendran and Nur Dinie Junaidi, while Chai Phei Gan and Ngoi Soo Mun hail from the Cancer Immunology & Immunotherapy department.
As the only Non-Governmental Organisation (NGO) in the country dedicated to researching cancers that commonly affect Malaysians and the region, CRMY relies on donations to sustain its work and research efforts.
“The Support Our Scientist campaign embodies our commitment to advancing cancer research in Malaysia. With every donation, we move closer to developing groundbreaking strategies for early cancer detection and improving patient outcomes,” said Andy Khoo, CEO of CRMY.
The Digital Health Research Unit focuses on developing and testing innovative strategies for early cancer detection, particularly for common cancers in Asian populations. One of their key initiatives is a mobile application, MeMoSA (Mobile Mouth Screening Everywhere), which enables early detection of mouth cancer by connecting communities to dental healthcare professionals.
The unit aims to enhance the App’s reach beyond the three pilot communities of Kampung Peros, Kampung Pasir Hulu, and Kampung Entangor in Sarawak.
The Cancer Immunology & Immunotherapy Research Unit focuses on developing immunotherapy treatments to improve patient outcomes. They are currently working on a Malaysian-made vaccine for oral cancer, which is often diagnosed at a late stage, leading to poor survival rates. This vaccine aims to train the immune system to detect and destroy cancer cells, offering hope to patients with advanced-stage oral cancer.
The team is working to expand the usage of the oral cancer vaccine to other cancers that are common in our regions to ensure more patients can benefit from this ground-breaking treatment. It is also our continuous effort to identify new vaccine targets for cancers to improve our current vaccine formulation.
The donation can start from as low as RM 1 to RM 1000 (or even more is welcome) a month, or any amount for a one-time contribution if preferred. This flexible approach ensures inclusivity, making it feasible for everyone to participate in the fight against cancer. Every donation is crucial as it’s not just a contribution but a lifeline for those battling cancer.
“Your support enables us to continue our research, develop innovative treatments, and ultimately save lives. Join us in the fight against cancer. Your contribution can make a real difference. Donate today and be a part of the cure, ” CRMY said.
To support “SOS” campaign and contribute to groundbreaking cancer research, visit https://bit.ly/CRMY_SOS
(Press Release)
Category: MJN enews
